MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$19,896K
Net Income
$3,777K
Net Profit Margin
18.98%
EPS
$0.05
Unit: Thousand (K) dollars
Revenue Breakdown
Chiesi
Pfizer
Fiocruz
License And Service
Revenue Breakdown
labor and related expense
Segment reporting, other segment...
Income (loss) from continuing op...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
19,896
33,750
2,481*
17,851
Cost of revenues
7,762
4,127
5,701*
8,324
Research and development expenses, net
4,351
5,426
3,881*
4,467
Selling, general, and administrative expenses
3,111
3,051
3,353*
2,929
Operating income (loss)
4,672
21,146
-10,453*
2,131
Financial expenses
494
193
-254*
180
Financial income
682
188
243*
288
Financial income (expenses), net
188
-5
497*
108
Income (loss) before taxes on income
4,860
21,141
-9,957*
2,239
Taxes on income
1,083
2,824
425*
-116
Net income (loss)
3,777
18,317
-10,382
2,355
Basic EPS
0.05
0.23
-0.134
0.03
Diluted EPS
0.05
0.22
-0.141
0.03
Basic Average Shares
79,986,325
79,848,892
77,693,133
79,281,685
Diluted Average Shares
82,560,235
83,048,596
73,552,528
80,814,564
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Chiesi
$14,035K
(43.32%↑ Y/Y)
Pfizer
$4,279K
(-24.23%↓ Y/Y)
Fiocruz
$1,514K
Product
$19,828K
(28.42%↑ Y/Y)
License And Service
$68K
(-68.81%↓ Y/Y)
Total revenue
$19,896K
(27.07%↑ Y/Y)
Financial income
$682K
(150.74%↑ Y/Y)
Operating income (loss)
$4,672K
(298.63%↑ Y/Y)
Financial income
(expenses), net
$188K
(136.79%↑ Y/Y)
Cost of revenues
$7,762K
(32.23%↑ Y/Y)
Research and development
expenses, net
$4,351K
(-27.39%↓ Y/Y)
Selling, general, and
administrative expenses
$3,111K
(18.56%↑ Y/Y)
Financial expenses
$494K
(-36.91%↓ Y/Y)
Income (loss) before
taxes on income
$4,860K
(635.25%↑ Y/Y)
Net income (loss)
$3,777K
(2203.05%↑ Y/Y)
Taxes on income
$1,083K
(117.91%↑ Y/Y)
Buy us a coffee
Protalix BioTherapeutics, Inc. (PLX)
Protalix BioTherapeutics, Inc. (PLX)